HomeZ1TS34 • BVMF
add
Zoetis Inc Bdr
Previous close
R$61.26
Day range
R$60.54 - R$63.66
Year range
R$46.85 - R$69.86
Market cap
77.51B USD
Avg Volume
2.69K
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 2.32B | 4.70% |
Operating expense | 845.00M | 8.89% |
Net income | 581.00M | 10.67% |
Net profit margin | 25.08 | 5.73% |
Earnings per share | 1.40 | 12.90% |
EBITDA | 828.00M | 8.52% |
Effective tax rate | 20.63% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.99B | -2.65% |
Total assets | 14.24B | -0.34% |
Total liabilities | 9.47B | 1.85% |
Total equity | 4.77B | — |
Shares outstanding | 447.79M | — |
Price to book | 5.76 | — |
Return on assets | 13.39% | — |
Return on capital | 16.22% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 581.00M | 10.67% |
Cash from operations | 905.00M | 0.89% |
Cash from investing | 126.00M | 160.00% |
Cash from financing | -745.00M | -87.66% |
Net change in cash | 273.00M | -4.88% |
Free cash flow | 1.25B | 66.62% |
About
Zoetis Inc. is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total revenue. Contemporaneous with the spinoff in June 2013 S&P Dow Jones Indices announced that Zoetis would replace First Horizon National Corporation in the S&P 500 stock market index. Wikipedia
Founded
1952
Headquarters
Website
Employees
13,800
